Not exact matches
The technology's possibilities are staggering — in theory, allowing medical scientists to do everything from cure genetic
disorders like sickle cell disease to identify
gene targets for combating HIV.
That could eventually lead to new drugs that selectively
target the
gene, which McCarthy says, «could be a strategy for treating mood or sleep
disorders.»
Yang said the study not only indicated which
genes are affected by traumatic brain injury and linked to serious disease, but also might point to the
genes that govern metabolism, cell communication and inflammation — which might make them the best
targets for new treatments for brain
disorders.
«By greatly narrowing the specific
genes involved in social
disorders, our findings will help uncover
targets for treatment and provide measures by which these and other treatments are successful in alleviating the desperation of autism, anxiety and other
disorders,» says Korenberg.
NIPD for single
gene disorders in a fetus is diagnostic, as it
targets specific genetic changes present in a high risk family.
However, this strong correlation between RORA and aromatase levels was not observed in females with autism spectrum
disorder, suggesting that they may have compensatory mechanisms for regulating RORA
target genes to offset RORA deficiency.
According to Sinclair, all of the mammalian SIRT
genes (and their proteins) are possible drug
targets for therapies aimed at extending life, as well as staving off age - related illnesses, such as Alzheimer's disease, cancers and metabolic
disorders, like diabetes.
Gene therapy, which often employs viruses to deliver the good genes to a body's target cells, has been known to trigger severe immune responses and was blamed for the death of an 18 - year - old in 1999, who was receiving gene therapy for a hereditary metabolic disor
Gene therapy, which often employs viruses to deliver the good
genes to a body's
target cells, has been known to trigger severe immune responses and was blamed for the death of an 18 - year - old in 1999, who was receiving
gene therapy for a hereditary metabolic disor
gene therapy for a hereditary metabolic
disorder.
Although variations in the NPAS1 and NPAS3
genes have been linked to brain
disorders including autism, they aren't obvious drug
targets because their function is most important in early life.
«A better understanding of the brain region and cell type - specific binding
targets of Hnrnph1 will tell us more about the function of this
gene and possibly identify new therapeutic strategies for minimizing risk and treating psychostimulant addiction — a
disorder for which there is currently no FDA - approved drug,» explained corresponding author Camron Bryant, PhD, assistant professor of Pharmacology and Experimental Therapeutics & Psychiatry at BUSM.
Other blood
disorders that have shown significant benefit from
targeted gene therapy in small trials include hemophilia (specifically, factor IX deficiency), severe beta - thalassemia (deficiency for the adult beta - globin
gene) and leukemia, where the patient's immune cells were treated to enable them to recognize cancer cells and destroy them.
Drug discovery for genetic diseases: Screening technologies are applied to identify chemical compounds able to inhibit REST function, a major
target gene in Huntington's disease, and will serve as a paradigm for high - throughput screening approaches applied to neurological
disorders.
This technology helps researchers connect mutations in the so - called genomic «dark matter» with the
genes they affect, potentially revealing new therapeutic
targets for genetic
disorders.
Targeted gene therapy, which would affect smooth muscle cells but not skeletal muscle, holds promise for treatment of these and other
disorders.
There are
genes that, when mutated, cause
disorders of language, speech and comprehension, and statistical analyses of our genomes show that these
genes were
targets of Darwinian natural selection.
Genes regulating the cerebral levels of important neurotransmitters (dopamine, serotonin, GABA, etc.) or signal transmission efficiency (neurotransmitter receptors and genes) have been targeted in association studies of major psychiatric disorders such as schizophrenia, bipolar disorders, attention deficit / hyperactivity disorder (ADHD), and autism [84], as well as of personality traits
Genes regulating the cerebral levels of important neurotransmitters (dopamine, serotonin, GABA, etc.) or signal transmission efficiency (neurotransmitter receptors and
genes) have been targeted in association studies of major psychiatric disorders such as schizophrenia, bipolar disorders, attention deficit / hyperactivity disorder (ADHD), and autism [84], as well as of personality traits
genes) have been
targeted in association studies of major psychiatric
disorders such as schizophrenia, bipolar
disorders, attention deficit / hyperactivity
disorder (ADHD), and autism [84], as well as of personality traits [85].